多替拉韦钠盐

多替拉韦钠盐（CAS 1051375-19-9）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

这个物质在各数据库里的编号

数据库记载的用途

• Dolutegravir (brand names: Tivicay and Tivicay PD) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV in combination with:
• Other HIV medicines in children and infants who are at least 4 weeks of age and weigh at least 6.6 lb (3 kg) and who meet specific requirements, as determined by a health care provider; or
• Rilpivirine (brand name: Edurant) as a complete regimen in adults who meet specific requirements, as determined by a health care provider. (A fixed-dose combination tablet containing dolutegravir and rilpivirine [brand name: Juluca] is also available.)
• Dolutegravir is always used in combination with other HIV medicines.
• Integrase Strand Transfer Inhibitor (INSTIs)
• Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA.

它在各数据库里的别名

DOLUTEGRAVIR SODIUM; 1051375-19-9; Dolutegravir sodium salt; TIVICAY PD; 1Q1V9V5WYQ; CHEBI:76007; GSK-1349572A; JULUCA COMPONENT DOLUTEGRAVIR SODIUM; TRIUMEQ COMPONENT DOLUTEGRAVIR SODIUM; DTXSID201027849; RefChem:56965; DTXCID001513426; Tivicay; Dolutegravir sodium [USAN]; Dolutegravir (sodium); GSK1349572 sodiuM salt

计算机算出的分子描述符

数据库摘要

Dolutegravir sodium salt · CAS 1051375-19-9 · C20H18F2N3NaO5. UNII 1Q1V9V5WYQ.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。